memantin sandoz 10 mg/1 tableta filmom obložena tableta
sandoz d.o.o. - Мемантина - filmom obložena tableta - 10 mg/1 tableta - 1 filmom obložena tableta sadrži: 10 mg memantin hidrohlorida što odgovara 8,31 mg memantina
actemra 80 mg/4 ml koncentrat za rastvor za infuziju
roche d.o.o.roche ltd. - tocilizumab - koncentrat za rastvor za infuziju - 80 mg/4 ml - 4 ml koncentrata za rastvor za infuziju sadrži: 80 mg tocilizumaba ( 20 mg/ml )
actemra 200 mg/10 ml koncentrat za rastvor za infuziju
roche d.o.o.roche ltd. - tocilizumab - koncentrat za rastvor za infuziju - 200 mg/10 ml - 10 ml koncentrata za rastvor za infuziju sadrži: 200 mg tocilizumaba (20 mg/ml)
actemra 400 mg/20 ml koncentrat za rastvor za infuziju
roche d.o.o.roche ltd. - tocilizumab - koncentrat za rastvor za infuziju - 400 mg/20 ml - 20 ml koncentrata za rastvor za infuziju sadrži: 400 mg tocilizumaba ( 20 mg/ml )
forxiga
astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. osim drugih lijekova za liječenje šećerne bolesti tipa 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
daforbis 10 mg filmom obložene tablete
viatris limited, damastown industrial park, mulhuddart, dublin, irska - dapagliflozin - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 10 mg dapagliflozina
daforbis 5 mg filmom obložene tablete
viatris limited, damastown industrial park, mulhuddart, dublin, irska - dapagliflozin - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 5 mg dapagliflozina
dagrafors 10 mg filmom obložene tablete
krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - dapagliflozin propandiolhidrat - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 10 mg dapagliflozina (u obliku dapagliflozin propandiolhidrata)
dagrafors 5 mg filmom obložene tablete
krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - dapagliflozin propandiolhidrat - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 5 mg dapagliflozina (u obliku dapagliflozin propandiolhidrata)